Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06159348 · ClinicalTrials.gov registry record
Pilot Feasibility Study of a Novel Non-invasive Device for Diagnosis of Anemia
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 25
- Enrollment target
NCT06159348 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 25 participants.
The verdict
NCT06159348 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
In low-resource areas of the world, anemia screening relies on analyzing a blood sample and is generally carried out in health facilities. Current anemia screening approaches have not yielded satisfactory results due to critical limitations including lack of a) reliable access to laboratory facilities, b) reliable non-invasive out-of-hospital screening tools for community health-workers, c) integration of anemia data across health systems and d) distinction between hemolytic and nutritional causes. Currently available non-invasive tools have unacceptably low accuracy and cannot distinguish between nutritional and hemolytic etiologies. Prototype Anemia Diagnostic Assistant (ADA) We have developed a prototype Anemia Diagnostic Assistant for non-invasive, simultaneous detection of two markers of anemia, blood hemoglobin and the End-Tidal carbon monoxide levels. The device comprises an optical sensor module and ETCO breath sampling module. The unique and significant advantage of the instrument is its ability to detect, independently, two orthogonal variables that are required for differential diagnosis of the nutritional and hemolytic anemia: 1. Hemoglobin concentration using a non-invasive diffuse reflectance spectroscopy. Using high-fidelity, 11 wave-length spectral sensor, the device will provide optical quantification of hemoglobin levels. Optical hemoglobin sensing using diffused reflectance spectroscopy is well known, however; using traditional spectrophotometry instrumentation is very costly and thus impractical for this project. As a solution, we propose to use a validated commercially-available high accuracy 11-wavelength sensor within the visual and near-infrared (IR) range of the spectrum. The 11-wavelength spectrum will allow for sufficient accuracy in measuring the reflectance AND transmittance at isosbestic wavelengths on hemoglobin extinction curve as well as to compensate for the presence of melanin, which is a major interferant in optical determinat
Interventions
- DIAGNOSTIC_TEST Anemia Diagnostic Assistant (ADA)
- DIAGNOSTIC_TEST Serum hemoglobin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-11-30 |
| Est. Completion | 2023-12-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06159348
The ClinicalTrials.gov registry entry for NCT06159348 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Anemia Diagnostic Assistant (ADA) is the first listed.
NCT06159348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06159348 about?
NCT06159348 is a clinical study titled "Pilot Feasibility Study of a Novel Non-invasive Device for Diagnosis of Anemia". In low-resource areas of the world, anemia screening relies on analyzing a blood sample and is generally carried out in health facilities. Current anemia screening approaches have not yielded satisfactory results due to critical limitations including lack of a) reliable access to laboratory faciliti...
What is the current status of trial NCT06159348?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2023-11-30. Estimated completion is 2023-12-12.
What interventions are being tested in trial NCT06159348?
The interventions under investigation include: Anemia Diagnostic Assistant (ADA) (DIAGNOSTIC_TEST), Serum hemoglobin (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06159348?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.